Abstract Polymorphic non-coding variants at the NOS1AP locus have been associated with the common cardiac, metabolic and neurological traits and diseases. Although, in vitro gene targeting-based cellular and biochemical studies have shed some light on NOS1AP function in cardiac and neuronal tissue, to enhance our understanding of NOS1AP function in mammalian physiology and disease, we report the generation of cre recombinase-conditional Nos1ap over-expression transgenic mice (Nos1ap Tg ).
Conditional transgenic mice were generated by the pronuclear injection method and three independent, single-site, multiple copies integration event-based founder lines were selected. For heart-restricted overexpression, Nos1ap
Tg mice were crossed with Mlc2v-cre and Nos1ap transcript over-expression was observed in left ventricles from Nos1ap
Tg ; Mlc2v-cre F 1 mice. We believe that with the potential of conditional over-expression, Nos1ap
Tg mice will be a useful resource in studying NOS1AP function in various tissues under physiological and disease states.
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Introduction
NOS1AP encodes the C-terminal PDZ domain ligand of neuronal nitric oxide synthase (nNOS) and was originally cloned from a rat hippocampal cDNA library (Jaffrey et al. 1998 ). NOS1AP has an Nterminal PTB domain and a C-terminal PDZ binding region (Jaffrey et al. 1998) . In neuronal tissues, NOS1AP has been shown to (a) compete with PSD95 for interaction with the nNOS PDZ domain through its C-terminus, suggesting that NOS1AP may influence nNOS function at synaptic and post-synaptic structures (Jaffrey et al. 1998) , (b) act as an adaptor protein linking nNOS to its downstream targets like Dexras1 (Fang et al. 2000) and synapsins (Jaffrey et al. 2002) through its PTB (phosphotyrosine binding) domain, (c) regulate dendritic spine formation and patterning at synapses through its PTB-domain mediated interactions with carboxypeptidase E (Carrel et al. 2009 ) and Scribble/Git1 (Richier et al. 2010) , and (d) mediate activation of the nNOS-p38MAPK pathway during neuronal death from excitotoxicity (Li et al. 2013) . NOS1AP also forms a protein complex with SCRIB and VANGL to regulate cell polarity and migration, and is associated with breast cancer progression (Anastas et al. 2012) .
In addition to these cellular and biochemical studies, mainly focused on NOS1AP function in neuronal tissues, genetic association studies have identified common noncoding variants mapping at the locus encompassing NOS1AP to be associated with complex cardiac, metabolic and neuronal traits/diseases including the electrocardiographic QT interval (Arking et al. 2006; Newton-Cheh et al. 2009; Pfeufer et al. 2009 ), type 2 diabetes (Becker et al. 2008; Prokopenko et al. 2009 ) and schizophrenia (Brzustowicz et al. 2004 ). The QT interval-associated variants at the NOS1AP locus are also associated with risk for sudden cardiac death (SCD) in the general population Kao et al. 2009 ) with a hazard ratio of *1.4 and act as genetic modifiers of long QT syndrome (LQTS) phenotype by influencing QT interval duration and enhancing SCD risk up to tenfold (Crotti et al. 2009; Tomas et al. 2010) . However, like most other genetic association studies, the identity, function and mechanisms of action of the underlying noncoding sequence variants and genes remain unknown. There is limited knowledge of NOS1AP function in nonneuronal tissues, a function revealed through genetic association studies. Knockdown of nos1ap expression in zebrafish using morpholinos leads to shortened action potential duration (APD) in excised hearts from developing embryos (Milan et al. 2009) , and overexpression of Nos1ap in guinea pig ventricular myocytes using in vivo gene transfer leads to shortened APD mediated by inhibition of L-type calcium currents (Chang et al. 2008) . These findings suggest that altered NOS1AP expression level influences cardiac cellular electrophysiology and thus is the most likely causal gene underlying trait association and disease risk. Since only noncoding variants at the NOS1AP locus have been associated with common cardiac, metabolic and neuronal traits/diseases in humans, it is likely that expression level of NOS1AP in various cell types is the primary mechanism through which NOS1AP influences disease risk and trait variation.
Existence of gene targeting methods including a conditional knockout and conditional over-expression design make mice an ideal model system to study gene function. NOS1AP function in neuronal and cardiac tissues has so far been evaluated using in vitro and ex vivo experimental systems. To gain further insights into NOS1AP function at the tissue, organ and organismal levels, here we report the creation of a cre recombinaseconditional, Nos1ap-over-expression transgenic mouse and evaluation of heart-restricted Nos1ap over-expression. In parallel, the International Knockout Mouse Consortium has recently generated the Nos1ap conditional knockout mice (KOMP-CSD ID: 84676).
Materials and methods

Generation of cre recombinase-conditional
Nos1ap over-expression transgenic mice Mouse Nos1ap full length ORF (NM_001109985) was PCR-amplified from a mouse embryonic day 17.5 cDNA library (Clontech, CA) using gene-specific primers (Nos1apORF_XhoIF and Nos1apORF_No-tIR; Supplementary Table 1 ). The 1.5 kb Nos1ap ORF ampilcon was cloned into the pCLIP vector (George et al. 2007 ) (gift from Andras Nagy) as a XhoI-NotI fragment for conditional transgene expression. The identity of the conditional clone was confirmed by Sanger sequencing of the entire insert using cloning primers and internal gene-specific sequencing primers Nos1apORF_IntF and Nos1apORF_IntR (Supplementary Table 1 ). The sequence of loxP sites in the vector backbone was confirmed using the sequencing primers loxP_Seq and Nos1apORF_IntR (Supplementary Table 1 ). The production of conditional transgenic mice from pronuclear injection of *12.1 kb long ScaI-linearized Nos1ap-pCLIP plasmid DNA into fertilized mouse eggs (FVB strain) was performed by the Texas A&M Institute for Genomic Medicine.
Characterization of conditional transgenic founders
Conditional transgenic founders were identified by PCR specific to lacZ (LacZ_F and LacZ_R primers; Supplementary Table 1) and mouse Nos1ap cDNA (Nos1ap_cDNA_F and Nos1ap_cDNA_R primers; Supplementary Table 1) , and by Southern blotting using lacZ-specific probes (amplified from pCLIP using SouthernProbe_F and SouthernProbe_R primers; Supplementary Table 1) . Southern blot analysis of genomic DNA isolated from mouse tail-tips was performed following standard protocols using a 32 Plabeled lacZ probe (Perkin Elmer, MA). The transgene DNA has two EcoRV sites that lead to a *6.8 kb long restriction fragment when probed with a lacZ-specific probe. Transgene insertion sites were identified using fluorescent in situ hybridization (FISH) as described by Dutra et al. (1996) . Briefly, metaphase chromosomes were prepared from cultured peripheral blood cells from tail vein bleeds by doing a mitotic arrest with colcemid (0.1 lg/ml, 30 min), followed by hypotonic treatment (0.075 M KCl, 20 min, 37°C) and fixation with methanol/acetic acid (3:1). On each slide 50 ng Nos1ap-pCLIP plasmid DNA-derived probe was applied along with tenfold excess of Cot1 DNA for repeat blocking. Hybridization mixture (10 ll) containing the labeled probe in 50 % (v/v) formamide, 29 sodium saline citrate, and 10 % (w/v) dextran sulfate was denatured at 75°C for 10 min and incubated at 37°C for 30 min for pre-annealing, and then added to denatured slides and hybridized at 37°C for at least 18 h. After washes slides were counter stained with 4 0 ,6-diamidino-2-phenylindole. (Chen et al. 1998) were provided by Kenneth R. Chien (Massachusetts General Hospital, Boston), and were genotyped for the knock-in cre allele using cre-specific primers (Mlc2v-cre_F and Mlc2c-cre_R; Supplementary Table 1) . Mlc2v-cre mice were maintained on a mixed background by breeding to FVB mice. For heart-restricted overexpression, FVB-Nos1ap
Tg mice were crossed with Mlc2v-cre mice to generate Nos1ap
Tg ; Mlc2v-cre F 1 mice. All molecular analyses of heart-restricted Nos1ap over-expression were performed in these adult (3-4 months) F 1 mice and their wild-type control littermates.
The cre-recombinase conditional Nos1ap overexpression transgenic mice described here will be available to the research community upon acceptance of the manuscript.
RNA expression
Adult mice were euthanized using inhaled isoflurane in a closed chamber. Left ventricles were dissected and snap-frozen using liquid N 2 and stored at -80°C. Total RNA was isolated from *10 mg dry tissue (frozen tissue) using TRIzol. DNase digestion and RNA clean-up was performed using RNeasy Mini kit and RNase-Free DNase set (Qiagen, CA), following manufacturer's instructions. cDNA was synthesized by oligo-dT primed reverse transcription performed on 1 lg total RNA using SuperScript III First-Strand Synthesis System (Invitrogen, NY), following manufacturer's instructions. Quantitative expression analysis of Nos1ap was performed using mouse-specific TaqMan Gene Expression assay (Mm01290688_m1) (Applied Biosystems, NY). Real-time quantitative PCR (qPCR) was performed on a 7900HT Fast RealTime PCR System (Applied Biosystems, NY) and analyzed using Sequence Detection System Software v.2.1 (Applied Biosystems, NY). Expression was measured in technical triplicates and the averages of the threshold cycle (C t ) values were used for analysis. Actb expression, assessed using mouse Actb Endogenous Control TaqMan Gene Expression assay (Applied Biosystems, NY), was used for normalization.
Statistical analyses
All comparisons between two groups of mice were performed by comparing means using Student's t test. We used an alpha level of 0.05 for all statistical tests.
Results and discussion
For generation of cre recombinase-conditional Nos1ap over-expression transgenic mice, Nos1ap ORF (NM_001109985), with start and stop codons, was cloned as an XhoI-NotI fragment into the pCLIP vector (George et al. 2007 ) downstream of the loxP-flanked (floxed) lacZ-neomycin fusion gene (bgeo) (Fig. 1) . In this construct, a CMV enhancer combined with a chicken b-actin promoter (pCAGG) (Okabe et al. 1997) drives the expression of floxed bgeo followed by three polyadenylation (pA) signals. These components are followed by the Nos1ap ORF, which is then followed by an IRES-puromycin-pA cassette. We used the pCAGG (Okabe et al. 1997) to drive the expression of a conditional transgene since the Nos1ap endogenous promoter is not characterized. We used pCLIP as the vector for its ability to generate cre recombinaseconditional over-expression as in the presence of cre recombinase, the floxed bgeo cassette is deleted, leaving the gene of interest under the control of a strong constitutive enhancer-promoter element. We utilized the cre-loxP system (Sauer and Henderson 1988; Sternberg et al. 1981) for creating conditional mice which can be used to study the effects of both tissuerestricted as well as ubiquitous over-expression of Nos1ap. Although pCLIP has two selection markers, neomycin and puromycin, we did not use these selection markers in generation of transgenic mice. *12.1 kb long ScaI-linearized Nos1ap-pCLIP plasmid DNA was used for pronuclear injection of fertilized mouse eggs (FVB) to create the conditional transgenic founders.
Out of a total of 35 live pups, three transgenic founders (Nos1ap Tg , IDs 112, 314 and 333) were identified by PCR on genomic DNA using primers specific to lacZ and Nos1ap cDNA, and were confirmed by Southern blotting using a lacZ-specific probe (Fig. 1, data not shown) . These three founder mice were crossed with FVB mice to generate FVBNos1ap
Tg F 1 mice for maintenance of individual lines (henceforth referred to as the 112, 314 and 333 lines). We then analyzed FVB-Nos1ap
Tg F 1 mice to identify the site of transgene integration by FISH using a Nos1ap-pCLIP plasmid DNA-derived probe. All three lines were found to have a single site of transgene integration, in chromosome 4, chromosome 12 and chromosome 2 for the 112, 314 and 333 lines, respectively (Fig. 1) . Normal Mendelian segregation of the transgenic locus was observed for all 3 lines and FVB-Nos1ap
Tg F 1 mice were indistinguishable in appearance and behavior from wild type littermates.
For heart-restricted over-expression, FVBNos1ap
Tg cre-conditional mice from the 112, 314 and 333 lines were crossed with Mlc2v-cre driver mice (Chen et al. 1998) 
to generate Nos1ap
Tg ; Mlc2v-cre F 1 mice. The FVB-Nos1ap
Tg cre-conditional transgenic mice could also be used to study the effects of global Nos1ap over-expression by crossing with a ubiquitous cre line such as CMV-cre (Schwenk et al. 1995) . cre expression in the knock-in Mlc2v-cre mice recapitulates endogenous Mlc2v expression (Chen et al. 1998) and is expressed in heart starting as early as embryonic day 9.5 (Robson et al. 2010) . Expression of Nos1ap transcript was evaluated in left ventricles excised from adult (3-4 months old) F 1 mice. Nos1ap transcript was found to be overexpressed in left ventricles of Nos1ap
Tg ; Mlc2v-cre mice from the 112 and 333 lines as compared to wild type littermates, t(18) = 5.77, p \ 0.001 for the 112 line and t(12) = 5.98, p \ 0.001 for the 333 line (Fig. 2) . On average Nos1ap
Tg ; Mlc2v-cre mice from the 112 line had higher expression levels as compared to mice from the 333 line. Nos1ap expression in left ventricles from mice carrying the Nos1ap
Tg locus, but not the Mlc2v-cre locus, was comparable to wild type littermates in the 112 and the 333 lines, t(11) = 0.66, p = 0.52 for the 112 line and t(10) = 0.07, p = 0.94 for the 333 line, indicating that over-expression from Nos1ap Tg locus is not ''leaky'' and is dependent on the presence of cre recombinase (Fig. 2) . No over-expression of Nos1ap transcript was observed in left ventricles of Nos1ap
Tg ; Mlc2v-cre mice from the 314 line, t(13) = 0.22, p = 0.83, indicating that the Nos1ap
Tg locus is transcriptionally silenced (Fig. 2) .
We chose to generate Nos1ap over-expression transgenic mice because of our interests in understanding Fig. 1 Generation of cre recombinase-conditional Nos1ap over-expression transgenic mice. a Nos1ap pCLIP transgene construct (adapted from George et al. 2007) , and representation for multiple copy head-to-tail insertion of the transgene and the expected 6.8 kb Southern band with lacZ probe (P) and EcoRV (E) digestion; bgeo b-galactosidase-neomycin fusion gene, pA signal, IRES internal ribosome entry site; b identification of transgenic founder by Southern blotting. Southern blotting performed on mouse tail genomic DNA digested with EcoRV and probed using lacZ specific probe. Lanes 3-8 have wild type mouse tail genomic DNA spiked with zero or multiple copies, as indicated, of Nos1ap pCLIP plasmid DNA per diploid genome. Mouse 112 was selected as a founder line for further experiments; c single site transgene integration in cre recombinase-conditional Nos1ap over-expression transgenic lines. Metaphase FISH using Nos1ap pCLIP plasmid specific probe performed in cultured peripheral blood cells of F 1 mice derived from cross between 112, 314, and 333 transgenic founders and FVB mice. Red dots in the left panel (white arrow) indicate site of integration on chromosome 4 (top), chromosome 12 (middle) and chromosome 2 (bottom) for 112, 314 and 333 lines, respectively cardiac repolarization, cardiac arrhythmias and SCD. Of the nearly dozen genes associated with QT interval Pfeufer et al. 2009 ), a quantitative and reproducible measure of ventricular repolarization, we chose Nos1ap because: (a) it is the single largest contributor to QT interval variation, (b) not much is known about its cardiac function in physiology and disease, and (c) genetic variations at NOS1AP are also associated with increased risk for SCD Kao et al. 2009 ), act as modifiers of LQTS (Crotti et al. 2009; Tomas et al. 2010) , and are associated with other common complex traits including schizophrenia (Brzustowicz et al. 2004 ) and glucose metabolism (Becker et al. 2008; Prokopenko et al. 2009 ). In fact, Nos1ap is the first gene to be associated with electrical propagation defects in the cardiac system. The creconditional design of the transgenic line can be used to overexpress Nos1ap in a variety of tissue types, both in adults and embryos, and we thus believe that these mice would be a useful resource. And to the best of our knowledge this is the first report of creation of a Nos1ap over-expression allele in mice. ;cre -mice, t(10) = 0.07, p = 0.94; c Same as a, mice derived from transgenic founder 314 (Tg ? ;cre ? n = 8, Tg -;cre -n = 7). No significant difference in expression level was observed between the two groups of mice derived from transgenic founder 314, t(13) = 0.22, p = 0.83
